Ultra-early hematoma growth in antithrombotic pretreated patients with intracerebral hemorrhage.

Citation data:

European journal of neurology, ISSN: 1468-1331, Vol: 25, Issue: 1, Page: 83-89

Publication Year:
2018
Captures 7
Readers 7
Social Media 2
Tweets 2
PMID:
28906578
DOI:
10.1111/ene.13458
Author(s):
J. Roquer; R. M. Vivanco-Hidalgo; J. Capellades; A. Ois; E. Cuadrado-Godia; E. Giralt-Steinhauer; C. Soriano-Tárraga; M. Mola-Caminal; M. Serra-Martínez; C. Avellaneda-Gómez; J. Jiménez-Conde; A. Rodríguez-Campello Show More Hide
Publisher(s):
Wiley-Blackwell
Tags:
Neuroscience; Medicine
Most Recent Tweet View All Tweets
article description
Patients with acute intracerebral hemorrhage (ICH) pretreated with antithrombotic drugs may have increased early hematoma growth, which would increase mortality risk. The effect of antiplatelet (AP) and vitamin K antagonist (VKA) pretreatment on ultra-early hematoma growth (uHG) and its relationship with mortality in patients with acute supratentorial ICH was analyzed.